Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022008901 - THERAPY OF POST-OPERATIVE NAUSEA AND VOMITING

Publication Number WO/2022/008901
Publication Date 13.01.2022
International Application No. PCT/GB2021/051720
International Filing Date 06.07.2021
IPC
A61K 31/40 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 45/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 1/08 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
08for nausea, cinetosis or vertigo; Antiemetics
Applicants
  • ACACIA PHARMA LTD [GB]/[GB]
Inventors
  • GILBERT, Julian Clive
  • FOX, Gabriel
  • GRISTWOOD, Robert William
Agents
  • POTTER CLARKSON
Priority Data
2010361.006.07.2020GB
2108238.309.06.2021GB
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) THERAPY OF POST-OPERATIVE NAUSEA AND VOMITING
(FR) THÉRAPIE CONTRE LA NAUSÉE ET LES VOMISSEMENTS POSTOPÉRATOIRES
Abstract
(EN) Amisulpride is useful in the therapy (particularly the prevention of) post-operative nausea and/or vomiting (PONV) in a patient, particularly wherein the patient has a high (≥30) BMI and/or the patient is a bariatric surgery patient.
(FR) L'amisulpride est utile dans la thérapie (en particulier dans la prévention) de la nausée et/ou des vomissements postopératoires (PONV) chez un patient, en particulier, lorsque le patient présente un IMC élevé (≥ 30) et/ou est un patient en chirurgie bariatrique.
Latest bibliographic data on file with the International Bureau